NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+1.82%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.3B
AUM Growth
+$1.3B
(-27%)
Cap. Flow
-$454M
Cap. Flow
% of AUM
-34.94%
Top 10 Holdings %
Top 10 Hldgs %
80.36%
Holding
42
New
–
Increased
2
Reduced
3
Closed
4
Top Buys
| 1 |
Senti Biosciences
SNTI
|
$11.2M |
| 2 |
Oric Pharmaceuticals
ORIC
|
$3.51M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$184M |
| 2 |
TEM
Tempus AI, Inc. Class A Common Stock
TEM
|
$134M |
| 3 |
NextNav
NN
|
$127M |
| 4 |
Geron
GERN
|
$9.83M |
| 5 |
Sagimet Biosciences
SGMT
|
$9M |
Sector Composition
| 1 | Healthcare | 92.44% |
| 2 | Consumer Staples | 6.6% |
| 3 | Industrials | 0.55% |
| 4 | Communication Services | 0.41% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BuzzFeed
BZFD
$72.6M
| $5.35M | 0.41% | 2,512,103 -1,321,370 | -34% | -$2.81M |
|
|
IVA
27
Inventiva
IVA
$861M
| $4.3M | 0.33% | 1,462,586 | – | – |
|
28
Synlogic
SYBX
$17M
| $3.62M | 0.28% | 2,922,772 | – | – |
|
29
X4 Pharmaceuticals
XFOR
$84.2M
| $3.54M | 0.27% | 14,986,793 | – | – |
|
|
ADAP
30
Adaptimmune Therapeutics
ADAP
$15.6M
| $3.36M | 0.26% | 17,079,778 | – | – |
|
|
INZY
31
DELISTED
Inozyme Pharma
INZY
| $2.22M | 0.17% | 2,437,689 | – | – |
|
|
OKUR
32
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $2.06M | 0.16% | 478,548 | – | – |
|
33
Marker Therapeutics
MRKR
$12M
| $2M | 0.15% | 1,625,678 | – | – |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| $1.4M | 0.11% | 6,147,260 | – | – |
|
|
IMA
35
ImageneBio, Inc. Common Stock
IMA
$150M
| $768K | 0.06% | 600,063 | – | – |
|
|
AFMD
36
DELISTED
Affimed
AFMD
| $320K | 0.02% | 442,648 | – | – |
|
37
Wheels Up
UP
$2.05B
| $107K | 0.01% | 106,125 | – | – |
|
|
38
Geron
GERN
$893M
| – | – | -2,776,409 | Closed | -$9.83M |
|
39
Lexicon Pharmaceuticals
LXRX
$400M
| – | – | -2,382,286 | Closed | -$1.76M |
|
|
40
NextNav
NN
$2.37B
| – | – | -8,189,156 | Closed | -$127M |
|
|
41
Sagimet Biosciences
SGMT
$244M
| – | – | -2,000,275 | Closed | -$9M |
|
|
TUYA
42
Tuya Inc
TUYA
$1.62B
| – | – | 0 | – | – |
|